Yahoo India Web Search

Search results

    • Zydus barred from selling cancer biosimilar, for now

      The Economic Times· 48 minutes ago

      The Delhi High Court has issued an interim injunction, restraining Zydus Lifesciences from selling its breast cancer drug Sigrima - a biosimilar version of Roche's Perjeta ...